• 1
    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al. (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 52, 338190.
  • 2
    Moreland LW, O'Dell JR, Paulus HE et al. (2012) A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of early aggressive rheumatoid arthritis trial. Arthritis Rheum 64, 282435.
  • 3
    O'Dell JR, Mikuls TR, Taylor TH et al. (2013) Therapies for active rheumatoid arthritis after methotrexate failure. NEJM 369, 30718.
  • 4
    Grigor C, Capell H, Stirling A et al. (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial. Lancet 364, 26369.
  • 5
    Rantalaiho V, Kautiainen H, Korpela M et al. (2013) Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 4-year follow-up results of a randomized clinical trial, the NEO-RACo trial. Ann Rheum Dis. [Epub ahead of print]. 10.1136/annrheumdis-2013-203497.
  • 6
    Smolen JS, Landewe R, Breedveld FC et al. (2013) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. [Epub ahead of print]. doi: 10.1136/annrheumdis-2013-204573.